Related Experiment Videos
Endometrial cancer: recent developments in evaluation and treatment
L M Chen1, K F McGonigle, J S Berek
1Department of Obstetrics and Gynecology, UCLA School of Medicine, USA.
Oncology (Williston Park, N.Y.)
|January 13, 2000
Summary
Endometrial carcinoma, a common gynecologic cancer, often presents early, but advanced stages have poor outcomes. Research explores hormonal influences and treatment options like chemotherapy and radiation.
Area of Science:
- Gynecologic Oncology
- Reproductive Endocrinology
Background:
- Endometrial carcinoma is the most frequent gynecologic malignancy in the U.S.
- While often diagnosed early, advanced-stage disease portends a poor prognosis.
- Excess estrogen is a primary etiological factor, suggesting distinct disease subtypes based on hormonal influence.
Purpose of the Study:
- To review the current understanding of endometrial carcinoma etiology, diagnosis, staging, and treatment.
- To highlight the importance of differentiating hormonally-influenced endometrial cancers.
- To discuss evolving adjuvant therapies and ongoing clinical trials.
Main Methods:
- Review of existing literature on endometrial carcinoma.
- Surgical staging protocols including hysterectomy, salpingo-oophorectomy, and selective lymphadenectomy.
- Discussion of current and investigational adjuvant treatments.
Main Results:
- Abnormal uterine bleeding is the predominant presenting symptom, necessitating endometrial sampling.
- Surgical staging is crucial for treatment planning.
- Adjuvant therapies include radiation, progestins, and chemotherapy, with ongoing trials optimizing combinations.
Conclusions:
- Early diagnosis and appropriate staging are critical for managing endometrial carcinoma.
- Understanding hormonal influences aids in classifying disease subtypes.
- Advances in adjuvant therapy, including combination chemotherapy, are vital for improving outcomes in advanced disease.